Scientific Program

Symposium 1:

States-of-Art: Personalized Surgery in Breast Cancer68
Venue: RM 1 (Vista 1+2)

Speakers

Omission of Sentinel Lymph Node Biopsy in Early Breast Cancer
TBD
(, )
Tailored Axillary Surgery in Axillary Node-Positive Early Breast Cancer
Andrea Barrio
(Memorial Sloan Kettering Cancer Center, U.S.A.)
Omission of Breast Surgery in Patients with Exceptional Response to Neoadjuvant Systemic Therapy
Tomomi Fujisawa
(Gunma Prefectural Cancer Center, Japan)

Panel Discussion 1:

Optimizing Treatment Sequence After CDK4/6 Inhibitors71
Venue: RM 2 (Grand 1)

Speakers

Resistance Mechanism of CDK4/6 Inhibitor: Primary or Acquired
TBD
(, )
What Is the Optimal Treatment Strategy After the First Line CDK4/6 Inhibitor?
Yoon-Sim Yap
(National Cancer Centre Singapore, Singapore)
Antibody Drug Conjugate for HR+HER2- MBC
TBD
(, )

Symposium 2:

Artificial Intelligence: Past, Present and Future64
Venue: RM 3 (Walker Hall 1)

Speakers

Practical Considerations and the Implementation of AI Tools for Breast Cancer Risk Prediction
Thijs Kooi
(Lunit Inc., Korea)
Artificial Intelligence in Real-World Experiences: Perspectives of Radiologists
Won Hwa Kim
(Kyungpook National Univ. Chilgok Hospital, Korea)
Artificial Intelligence in Breast Pathology: Current Landscape and Future Prospects
Miseon Lee
(The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)

IERBS 2024 1:

Current Status and Issues for Robotic and Endoscopic NSM88
Venue: RM 4 (Walker Hall 2)

Speakers

Patients Selection of Robotic and Endoscopic NSM for Beginners
Sae Byul Lee
(Asan Medical Center, Korea)
Ongoing Studies of Robotic or Endoscopic NSM
Chi Wei Mok
(Changi General Hospital, Singhealth Duke-NUS Breast Centre, Singapore)
Current Application of Robotic and Endoscopic NSM for High Risk of Breast Cancer Patients
Deborah Farr
(UT Southwestern Medical Center, U.S.A.)

GBCC-SSO Joint Session:

GBCC-SSO Joint Session104
Venue: RM 5 (Art Hall)

Oral Presentation 1:

Oral Presentation 1116
Venue: RM 6 (Grand 4)

Symposium 3:

The New Frontier of Endocrine Treatment for Breast Cancer65
Venue: RM 1 (Vista 1+2)

Speakers

Oral SERDs and Novel Endocrine Therapy Agents
Gun Min Kim
(Yonsei Cancer Center, Korea)
Targeting PI3K-mTOR-AKT Pathway in HR+ Breast Cancer
TBD
(, )
New Targets in Hormone Receptor Positive Breast Cancer
TBD
(, )

Panel Discussion 2:

Surgical Controversies Before and After Neoadjuvant Chemotherapy in the Era of Targeted Therapy72
Venue: RM 2 (Grand 1)

Speakers

Need to Complete Removal of Residual Microcalcifications? - In Case Highly Suggestive of Clinical pCR in MRI and with Residual Diffuse Microcalcification in Mammogram
Tari King
(Dana-Farber Brigham Cancer Center, U.S.A.)
Inflammatory Breast Cancer Following Good Response to Neoadjuvant Therapy: No Longer an Absolute Contraindication for Breast Conservation or Skin-Sparing Mastectomy? - Does Initial Extent or Severity Matter?
Stephanie M. Wong
(Jewish General Hospital, Canada)
Young Age Breast Cancer with cT1-3Nx, Low Grade, ER+ Tumor - Upfront Surgery or Neoadjuvant Chemotherapy?
TBD
(, )

Education Session 1:

What Radiologists Should Know for Optimal Interpretation in Patients Treated with NAC77
Venue: RM 3 (Walker Hall 1)

Speakers

Synergy from Surgical Viewpoint: A Holistic Imaging Interpretation with Intraoperative Experience
Joon Jeong
(Gangnam Severance Hospital, Korea)
Synergy from Oncological Viewpoint: Exploring Current Trends and Principles of Chemotherapy
Jae-Joon Kim
(Pusan National Univ. Yangsan Hospital, Korea)
Contemporary Imaging Insights and Interpretation Considerations for Patients Undergoing Neoadjuvant Systemic Therapy
Kazunori Kubota
(Dokkyo Medical Univ. Saitama Medical Center, Japan)

IERBS 2024 2:

Initiation and Troubleshooting of Robotic and Endoscopic NSM89
Venue: RM 4 (Walker Hall 2)

Speakers

Implication of Dry and Cadevaric Skill Labs for Robotic and Endoscopic NSM
Jeffrey Johnson
(Mayo Clinic, U.S.A.)
Robotic and Endoscopic NSM in Large & Ptotic Patients
Wen-Ling Kuo
(Chang Gung Memorial Hospital, Taiwan)
Managing Postop-Complications of Robotic and Endoscopic NSM Compared to Open NSM
Eisuke Fukuma
(Kameda Medical Center, Japan)

GBCC-JBCS Joint Session:

GBCC-JBCS Joint Session105
Venue: RM 5 (Art Hall)

Oral Presentation 2:

Oral Presentation 2117
Venue: RM 6 (Grand 4)

Plenary Lecture 1:

Plenary Lecture 1121
Venue: RM 1 (Vista 1+2)

Speakers

Dennis Slamon
(Univ. of California, Los Angeles, U.S.A.)

Satellite Symposium 1:

Satellite Symposium 1111
Venue: RM 1 (Vista 1+2)

Plenary Lecture 2:

Plenary Lecture 2122
Venue: RM 1 (Vista 1+2)

Speakers

Timothy Whelan
(McMaster Univ., Canada)

IERBS 2024 3:

Debate: Is Robot Assisted NSM Role Outside of Clinical Trials?90
Venue: RM 4 (Walker Hall 2)

Speakers

Pros
Antonio Toesca
(Candiolo Cancer Institute - IRCCS, Italy)
Cons
Andrea Barrio
(Memorial Sloan Kettering Cancer Center, U.S.A.)

Panel Discussion 3:

Beyond Borders: Breaking Barriers of Subtypes73
Venue: RM 2 (Grand 1)

Speakers

Tumor Agnostic Trials Across Subtypes in Metastatic Breast Cancer
Giuseppe Curigliano
(European Institute of Oncology and Univ. of Milano, Italy)
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer
Janice Tsang
(The Univ. of Hong Kong, Hong Kong)
Identifying Biological Entity That Is Sensitive to Immune Checkpoint Inhibitors
Hee Kyung Ahn
(Gachon Univ. Gil Medical Center, Korea)

Education Session 2:

Biomarkers Guided Treatment in ER+HER2- Breast Cancer78
Venue: RM 3 (Walker Hall 1)

Speakers

Liquid Biopsies Guided Treatment in ER+HER2- Breast Cancer
Sarat Chandarlapaty
(Memorial Sloan Kettering Cancer Center, U.S.A.)
Multigene Assays Based Decision for Extended Endocrine Therapy
Masakazu Toi
(Kyoto Univ. Hospital, Japan)
Biomarkers for Neoadjuvant Endocrine Therapy
Shigehira Saji
(Fukushima Medical Univ., Japan)

IERBS 2024 4:

PS Session91
Venue: RM 4 (Walker Hall 2)

Speakers

Robot-Assisted Breast Reconstruction
Benjamin Sarfati
(Institut Gustave Roussy, France)
Robot-Assisted Breast Reconstruction
Dong-Won Lee
(Yonsei Univ., Korea)
Autologous Breast Reconstruction - Japanese Trend and Our Strategy
Hiroki Mori
(Tokyo Medical and Dental Univ., Japan)

GBCC-TBCS Joint Session:

Asian Premenopausal Women with Breast Cancer106
Venue: RM 5 (Art Hall)

Oral Presentation 3:

Oral Presentation 3118
Venue: RM 6 (Grand 4)

Panel Discussion 4:

Subtype-Based Optimization of Locoregional Treatments for Small Tumors74
Venue: RM 2 (Grand 1)

Speakers

Treatment Approach in Small HER2+ or TNBC: Upfront Surgery vs Neoadjuvant Chemotherapy?
Marios Tasoulis
(The Royal Marsden Hospital, United Kingdom)
Small Luminal a Breast Cancer in Postmenopausal Women: SLNB Omission vs RT Omission?
TBD
(, )
Small Luminal a Breast Cancer in Postmenopausal Women: SLNB Omission vs RT Omission?
TBD
(, )

Education Session 3:

The Power of Genomics for Breast Cancer79
Venue: RM 3 (Walker Hall 1)

Speakers

Technology of Genomic Profiling in Breast Cancer: How to Interpret Genomic Testing
In Hye Song
(Asan Medical Center, Univ. of Ulsan College of Medicine, Korea)
Tumor vs cfDNA Analysis in Breast Cancer
Pedram Razavi
(Memorial Sloan Kettering Cancer Center, U.S.A.)
Actionable Mutations in Breast Cancer: Molecular Insights and Therapeutic Approaches
Min Hwan Kim
(Yonsei Univ. College of Medicine, Korea)

IERBS 2024 5:

Consensus Meeting: Voting Session92
Venue: RM 4 (Walker Hall 2)

Speakers

Introduction Consensus Meeting of IERBS & Summary of Previous Consensus Meeting of IERBS
Hung-Wen Lai
(Changhua Christian Hospital, Taiwan)

GBCC-BIG25:

GBCC-BIG2595
Venue: RM 5 (Art Hall)

Oral Presentation 4:

Oral Presentation 4119
Venue: RM 6 (Grand 4)

KEEP ME UPDATED

Sign up for GBCC Newsletter

Global Breast Cancer Conference Secretariat